Rubranol is widely used in the pharmaceutical industry as an intermediate in the synthesis of cardiovascular drugs. It plays a key role in the production of certain beta-blockers, helping to regulate heart rate and blood pressure. Due to its structural properties, it is also employed in the development of anti-arrhythmic medications.

In addition, Rubranol finds application in dermatological formulations, where it acts as a stabilizing agent in topical treatments for inflammatory skin conditions. Its compatibility with biological systems makes it suitable for use in controlled-release drug delivery systems.

Rubranol is also utilized in research settings for studying receptor binding mechanisms, particularly in neuropharmacology, where it aids in the development of new compounds targeting central nervous system disorders.